Firm Analyst
Maxim Group Jason McCarthy, Ph.D.
Aegis Capital David Bouchey

Avenue Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Avenue Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Avenue Therapeutics, Inc. or its management. Avenue Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.